Guidelines Summary

Ophthalmic involvement in patients with leukemia is common. Virtually all parts of the eye may become involved. Ophthalmic examination of patients with leukemia is important, as ocular involvement may be a sign of relapse. Isolated optic nerve involvement in ALL may be a red flag for early relapse.^[34] Earlier diagnosis may allow earlier treatment.

Follow-up

Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011 Dec 29. 365(26):2497-506. [QxMD MEDLINE Link].
The American Cancer Society medical and editorial content team. Key Statistics for Acute Myeloid Leukemia (AML). American Cancer Society. Available at https://www.cancer.org/cancer/acute-myeloid-leukemia/about/key-statistics.html. January 12, 2022; Accessed: July 22, 2022.
The American Cancer Society medical and editorial content team. Key Statistics for Chronic Lymphocytic Leukemia. American Cancer Society. Available at https://www.cancer.org/cancer/chronic-lymphocytic-leukemia/about/key-statistics.html. January 12, 2022; Accessed: July 22, 2022.
The American Cancer Society medical and editorial content team. Key Statistics for Acute Lymphocytic Leukemia (ALL). American Cancer Society. Available at https://www.cancer.org/cancer/acute-lymphocytic-leukemia/about/key-statistics.html. January 12, 2022; Accessed: July 22, 2022.
The American Cancer Society medical and editorial content team. Key Statistics for Chronic Myeloid Leukemia. American Cancer Society. Available at https://www.cancer.org/cancer/chronic-myeloid-leukemia/about/statistics.html. January 12, 2022; Accessed: July 22, 2022.
Karesh JW, Goldman EJ, Reck K, Kelman SE, Lee EJ, Schiffer CA. A prospective ophthalmic evaluation of patients with acute myeloid leukemia: correlation of ocular and hematologic findings. J Clin Oncol. 1989 Oct. 7(10):1528-32. [QxMD MEDLINE Link].
Schachat AP, Markowitz JA, Guyer DR, Burke PJ, Karp JE, Graham ML. Ophthalmic manifestations of leukemia. Arch Ophthalmol. 1989 May. 107(5):697-700. [QxMD MEDLINE Link].
Kincaid MC, Green WR. Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983 Jan-Feb. 27(4):211-32. [QxMD MEDLINE Link].
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May. 71 (3):209-249. [QxMD MEDLINE Link].
Zimmerman LE, Font RL. Ophthalmologic manifestations of granulocytic sarcoma (myeloid sarcoma or chloroma). The third Pan American Association of Ophthalmology and American Journal of Ophthalmology Lecture. Am J Ophthalmol. 1975 Dec. 80(6):975-90. [QxMD MEDLINE Link].
Radich JP. How I monitor residual disease in chronic myeloid leukemia. Blood. 2009 Oct 15. 114(16):3376-81. [QxMD MEDLINE Link].
Kaufman M, Rubin J, Rai K. Diagnosing and treating chronic lymphocytic leukemia in 2009. Oncology (Williston Park). 2009 Nov 15. 23(12):1030-7. [QxMD MEDLINE Link].
Russo V, Scott IU, Querques G, Stella A, Barone A, Delle Noci N. Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol. 2008 Jul-Aug. 18(4):619-23. [QxMD MEDLINE Link].
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009 Jul-Aug. 59(4):225-49. [QxMD MEDLINE Link]. [Full Text].
Ohkoshi K, Tsiaras WG. Prognostic importance of ophthalmic manifestations in childhood leukemia. Br J Ophthalmol. 1992 Nov. 76(11):651-5. [QxMD MEDLINE Link].
Curto ML, Zingone A, Acquaviva A, Bagnulo S, Calculli L, Cristiani L, et al. Leukemic infiltration of the eye: results of therapy in a retrospective multicentric study. Med Pediatr Oncol. 1989. 17 (2):134-9. [QxMD MEDLINE Link].
Abu el-Asrar AM, al-Momen AK, Kangave D, Harakati MS. Prognostic importance of retinopathy in acute leukemia. Doc Ophthalmol. 1995-1996. 91 (3):273-81. [QxMD MEDLINE Link].
Mirshahi R, Ghassemi F, Koochakzadeh L, Faranoush M, Ghomi Z, Mehrvar A, et al. Ocular Manifestations of Newly Diagnosed Acute Leukemia Patients. J Curr Ophthalmol. 2022 Jan-Mar. 34 (1):100-105. [QxMD MEDLINE Link].
Denier M, Tick S, Dubois R, Dulery R, Eller AW, Suarez F, et al. Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature. Medicina (Kaunas). 2022 Mar 21. 58 (3):[QxMD MEDLINE Link].
Delestre F, Blanche P, Bouayed E, Bouscary D, Mouthon L, Brezin A, et al. Ophthalmic involvement of chronic lymphocytic leukemia: a systematic review of 123 cases. Surv Ophthalmol. 2020 May 11. [QxMD MEDLINE Link].
Ohanian M, Borthakur G, Quintas-Cardama A, Mathisen M, Cortés JE, Estrov Z. Ocular granulocytic sarcoma: a case report and literature review of ocular extramedullary acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2013 Feb. 13(1):93-6. [QxMD MEDLINE Link].
Yassin MA, Ata F, Mohamed SF, Alkhateeb A, Naeem U, Al-Qatami AI, et al. Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review. Surv Ophthalmol. 2021 Jul 10. [QxMD MEDLINE Link].
Nagpal MP, Mehrotra NS, Mehta RC, Shukla CK. LEUKEMIC OPTIC NERVE INFILTRATION IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Retin Cases Brief Rep. 2016 Spring. 10 (2):127-30. [QxMD MEDLINE Link].
Adaniya A, Bazterrechea P, Trucco JI, Schlaen BA, Kusminsky G, Saravia MJ. Bilateral macular detachment: Choroid as a sanctuary of acute lymphoblastic leukemia. Am J Ophthalmol Case Rep. 2020 Sep. 19:100746. [QxMD MEDLINE Link].
Wu L, Calderon M, Hernandez G, Marbis J, Ramirez V. Bilateral exudative retinal detachment as the first sign of relapsing acute myelogenous leukaemia. Clin Experiment Ophthalmol. 2006 Aug. 34(6):623-5. [QxMD MEDLINE Link].
Veerappan Pasricha M, Callaway NF, Nguyen QD, Do DV. Serous retinal detachment as a presenting sign of acute lymphoblastic leukemia: A case report and literature review. Am J Ophthalmol Case Rep. 2021 Sep. 23:101142. [QxMD MEDLINE Link].
Mejia-Vergara AJ, Arnold AC, Bonelli L, Raviskanthan S, Lee AG. Papilledema and intracranial hypertension in leukemia: case series report and review. Can J Ophthalmol. 2021 Jul 21. [QxMD MEDLINE Link].
Kulbacki E, Schneider E, Wang E. Hypopyon' in the anterior chamber: unilateral ocular relapse of acute myeloid leukaemia in a 2-year-old girl. Br J Haematol. 2013 Aug. 162(3):293. [QxMD MEDLINE Link].
Deng J, Tsui E, Chapman CB. Blurred Vision. Leukemia relapse. JAMA Oncol. 2015 Oct. 1 (7):979-80. [QxMD MEDLINE Link].
Sykakis E, Patwary SN. Acute myeloid leukaemia presenting as gaze palsy. Case Rep Ophthalmol. 2011 Sep. 2(3):343-6. [QxMD MEDLINE Link].
McCoskey M, Reshef ER, Wolkow N, Yoon MK. Bilateral enlargement of all extraocular muscles: a presenting ophthalmic sign of hematologic malignancy. Orbit. 2022 Jun 22. 1-4. [QxMD MEDLINE Link].
Mohamed M, Oakley C, McEwen F, Connelley G. Leucapheresis for management of retinopathy in chronic myeloid leukaemia. BMJ Case Rep. 2015 Dec 1. 2015:[QxMD MEDLINE Link].
Mohammed MA, Doheim MF, Allam IY. Optic nerve sheath fenestration in leukemic patients having increased intracranial pressure: a prospective clinical trial. Int Ophthalmol. 2021 May 21. [QxMD MEDLINE Link].
Azad SV, Banerjee M, Parmanand K, Venkatesh P. Isolated optic nerve involvement in acute lymphoblastic leukaemia: a red flag for early relapse. BMJ Case Rep. 2021 Jun 28. 14 (6):[QxMD MEDLINE Link].
Hoover DL, Smith LE, Turner SJ, Gelber RD, Sallan SE. Ophthalmic evaluation of survivors of acute lymphoblastic leukemia. Ophthalmology. 1988 Feb. 95(2):151-5. [QxMD MEDLINE Link].

Media Gallery

A 4-year-old boy presented with sudden proptosis of his left eye.
Same patient as in the image above. A CBC revealed anemia (Hb 8.6 mg/dL), thrombocytopenia (64,000), and leukocytosis (12,900). The peripheral smear revealed the presence of blasts 28%, lymphocytes 44%, segmented 14%, monocytes 6%, bands 2%, metamyelocytes 1%, and myelocytes 1%. The boy was diagnosed with AML type M4-M5 chloroma of the left orbit.
CT scan reveals infiltration in the left orbit. Notice that the bone is uninvolved. A lumbar puncture revealed that the cerebral spinal fluid was clean of leukemic cells.
Systemic chemotherapy was instituted, and the proptosis resolved. Unfortunately, 4.5 months later, the boy passed away secondary to multiorgan failure.
An impending bilateral central retinal vein obstruction was discovered during a routine examination of a 76-year-old man. Further workup revealed a WBC count of 709,000, a hemoglobin count of 12 mg/dL, and a platelet count of 104,000. The man was eventually diagnosed with CML. This image is a red-free photograph of the right fundus. Notice the intraretinal hemorrhages.
Same patient as in the image above. This image is a red-free photograph of the left eye showing intraretinal hemorrhages.
A 14-year-old boy with a past medical history of ALL complained of a sudden loss of vision OD. Visual acuities were counting fingers OD and 20/20 OS. Notice the macular hemorrhage responsible for the loss of vision. Courtesy of Dr Rafael Jiménez.
Same patient as in the previous image. The hematological workup revealed a hemoglobin count of 5.6, a WBC count of 1800, and a platelet count of 3000. Courtesy of Dr Rafael Jiménez.

of 8

Author

Lihteh Wu, MD Ophthalmologist, Costa Rica Vitreo and Retina Macular Associates

Lihteh Wu, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Retina Specialists, Association for Research in Vision and Ophthalmology, Club Jules Gonin, Macula Society, Pan-American Association of Ophthalmology, Retina Society

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Bayer; Quantel Medical, Roche<br/>Received income in an amount equal to or greater than $250 from: Bayer Health; Quantel Medical, Roche.

Coauthor(s)

Joaquin Martinez, MD, MSc Consulting Staff, Department of Ophthalmology, Hospital Nacional de Ninos and Clinica Dr. Clorito Picado; Director of Retinal and Vitreous Clinic at Hospital Nacional de Ninos; Consulting Staff in Ultrosonography and Angiography, Clinica Oftalmologica Costarricense; Private Practice, San Rafael de Escazu, San Jose, Costa Rica

Joaquin Martinez, MD, MSc is a member of the following medical societies: Costa Rican Ophthalmology Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

Chief Editor

C Stephen Foster, MD, FACS, FACR, FAAO, FARVO Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Founder and President, Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institution

C Stephen Foster, MD, FACS, FACR, FAAO, FARVO is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Association of Immunologists, American College of Rheumatology, American College of Surgeons, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, American Uveitis Society, Association for Research in Vision and Ophthalmology, Massachusetts Medical Society, Royal Society of Medicine, Sigma Xi, The Scientific Research Honor Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Aldeyra Therapeutics (Lexington, MA); Bausch & Lomb Surgical, Inc (Rancho Cucamonga, CA); Eyegate Pharma (Waltham, MA); Novartis (Cambridge, MA); pSivida (Watertown, MA); Xoma (Berkeley, CA); Allakos (Redwood City, CA)<br/>Serve(d) as a speaker or a member of a speakers bureau for: Alcon (Geneva, Switzerland); Allergan (Dublin, Ireland); Mallinckrodt (Staines-upon-Thames, United Kingdom)<br/>Received research grant from: Alcon; Aldeyra Therapeutics; Allakos Pharmaceuticals; Allergan; Bausch & Lomb; Clearside Biomedical; Dompé pharmaceutical; Eyegate Pharma; Mallinckrodt pharmaceuticals; Novartis; pSivida; Santen; Aciont<br/>Stock for: Eyegate Pharma.

Additional Contributors

Andrew W Lawton, MD Neuro-Ophthalmology, Ochsner Health Services

Andrew W Lawton, MD is a member of the following medical societies: American Academy of Ophthalmology, Arkansas Medical Society, Southern Medical Association

Disclosure: Nothing to disclose.

Acknowledgements

Teodoro Evans, MD Consulting Surgeon, Vitreo-Retinal Section, Clinica de Ojos, Costa Rica

Disclosure: Nothing to disclose.

Brian R Younge, MD Professor of Ophthalmology, Mayo Clinic School of Medicine

Brian R Younge, MD is a member of the following medical societies: American Medical Association, American Ophthalmological Society, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.